Vétoquinol SA (VETOF)
90.80
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.056B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 4.96% |
| Valuation | |
| PE Ratio | 16.31 |
| PE Ratio (Forward) | |
| PS Ratio | 1.788 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 1.013 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 11.16% |
Profile
| Vétoquinol SA operates as a global animal health company. It supplies drugs and nonmedicinal products for the livestock (cattle and pigs) and pet (dogs and cats) markets. The firm designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region. It also manufactures antibiotic, anti-inflammatory, cardiology, and nephrology drugs. The company was founded by Joseph Frechin in 1933 and is headquartered in Lure, France. |
| URL | http://www.vetoquinol.com |
| Investor Relations URL | N/A |
| HQ State/Province | Bourgogne-Franche-Comte |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Sep. 11, 2026 |
| Last Earnings Release | Mar. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 05, 2025 |
Profile
| Vétoquinol SA operates as a global animal health company. It supplies drugs and nonmedicinal products for the livestock (cattle and pigs) and pet (dogs and cats) markets. The firm designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region. It also manufactures antibiotic, anti-inflammatory, cardiology, and nephrology drugs. The company was founded by Joseph Frechin in 1933 and is headquartered in Lure, France. |
| URL | http://www.vetoquinol.com |
| Investor Relations URL | N/A |
| HQ State/Province | Bourgogne-Franche-Comte |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Sep. 11, 2026 |
| Last Earnings Release | Mar. 27, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 05, 2025 |